Skip to main content
. 2018 Feb 27;51(4):e12451. doi: 10.1111/cpr.12451

Figure 6.

Figure 6

Combination therapy with coroglaucigenin and chloroquine enhances anti‐tumour activities in vivo. HT‐29 and SW480 tumour cells were injected into the right flanks of Nu/Nu mice (5 mice/group). When tumour volumes reached 50 mm3, mice were treated with indicated formulations every 2 d for 5 total treatments. (A) Images of tumour masses at day 18 in each mouse. (B) Tumour volumes at different time points. **< .01